Denmark banned ashwagandha primarily due to concerns about its potential negative effects on sex hormones and reproduction in both men and women.
The Danish authorities, specifically the Danish Veterinary and Food Administration (DVFA), have issued warnings against the consumption of ashwagandha and supplements containing it. This regulatory decision stems from evidence suggesting that the root of ashwagandha may have adverse impacts on the body's hormonal balance and reproductive health for both sexes.
Key Concerns Leading to the Ban
The decision to prohibit ashwagandha in Denmark is rooted in specific health concerns identified by regulatory bodies:
- Impact on Sex Hormones: Ashwagandha's root is believed to potentially interfere with the normal functioning and balance of sex hormones. Such interference could lead to unintended physiological changes.
- Reproductive Health Risks: There are concerns regarding ashwagandha's potential negative influence on reproductive functions, affecting fertility and overall reproductive well-being in both males and females.
Due to these identified risks to hormonal balance and reproductive health, Danish authorities advise against the consumption of ashwagandha and related products to safeguard public health.
